SEC
AMED

Seven Eight Capital’s Amedisys AMED Stock Holding History

Seven Eight Capital’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-17,800
Closed -$2.65M – 441
2021
Q3 		$2.65M Buy
+17,800
New +$3.7M 0.26% 127
2020
Q4 		– Sell
-4,200
Closed -$993K – 401
2020
Q3 		$993K Buy
+4,200
New +$955K 0.21% 170
2020
Q1 		– Sell
-9,500
Closed -$1.59M – 452
2019
Q4 		$1.59M Buy
+9,500
New +$1.41M 0.08% 360
2019
Q3 		– Sell
-4,000
Closed -$486K – 580
2019
Q2 		$486K Sell
4,000
-24,400
-86% -$2.9M 0.03% 495
2019
Q1 		$3.5M Buy
28,400
+13,300
+88% +$1.67M 0.18% 164
2018
Q4 		$1.77M Buy
15,100
+7,900
+110% +$931K 0.1% 264
2018
Q3 		$900K Sell
7,200
-10,800
-60% -$1.19M 0.05% 375
2018
Q2 		$1.54M Buy
+18,000
New +$1.32M 0.11% 232

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Seven Eight Capital's AMED Position: Q4 2021 in Review

Seven Eight Capital sold out of Amedisys (AMED) in Q4 2021, closing a stake of 17,800 shares — an estimated $2.65M sold.

Seven Eight Capital first reported a position in AMED in Q2 2018 and held it in 8 quarters. The position peaked at $3.5M in Q1 2019. 324 funds tracked by Wall St. Rank hold AMED as of Q4 2021.

  • Seven Eight Capital reported no remaining Amedisys position as of Q4 2021 after selling out during the quarter.
  • Seven Eight Capital sold 17,800 Amedisys shares in Q4 2021, an estimated $2.65M.
  • Seven Eight Capital first reported a position in Amedisys in Q2 2018 and held it in 8 quarters.
  • Seven Eight Capital's Amedisys position peaked at $3.5M in Q1 2019.
  • 324 funds tracked by Wall St. Rank held Amedisys as of Q4 2021.

Based on Seven Eight Capital's 13F filing for Q4 2021, filed 14 Feb 2022.